Pharma & Life Sciences

Annual Oligonucleotides for CNS Summit

The Annual Oligonucleotides for CNS Summit is a premier event dedicated to enhancing the discovery, translation, and clinical efficacy of CNS-targeted oligonucleotides.

3 weeks until it opens.

The essentials

Event details

Dates
19 August 2026 to 21 August 2026
Organiser
Hanson Wade
Industry
Pharma & Life Sciences

Agenda themes

Topics covered

  • Medical & Pharma

On stage

Speakers

  • Zhenjiu Liu, Principal Scientist, Alnylam
  • Andrew McCarthy, Oligo Data Science Leader, GSK
  • Fay Touti, Senior Director, Asset Discovery, Apellis
  • Meena Meena, SVP, Stoke Therapeutics
  • Barbara Calamini, Senior Director, Eli Lilly & Co
  • Hongkang Zhang, VP, Quiver Bioscience
  • Jimmy Weterings, Vice President & Head of Oligonucleotide Therapeutics, Bonito Bioscience
  • Carl Spickett, Director, Translational Medicine, Creyon Bio
  • Dan Elbaum, Chief Scientific Officer, QurAlis
  • Irina Antonijevic, Chief Medical Officer, Trace Neuroscience

Logistics

Where to stay

Places to stay near the venue.

Keep planning

Related events

Spot something wrong on this page? Report a correction and we will fix it.